Skip to main content
Nuclear Medicine and Molecular Imaging logoLink to Nuclear Medicine and Molecular Imaging
. 2010 Mar 13;44(1):90–93. doi: 10.1007/s13139-009-0015-2

Absent Sternum as the First Manifestation of Bone Metastasis on Bone Scintigraphy

Myung-Hee Sohn 1,3,, Seok Tae Lim 1,3, Young Jin Jeong 1, Dong Wook Kim 1,3, Hwan-Jeong Jeong 1,3, Chang-Yeol Yim 2,3
PMCID: PMC4042965  PMID: 24899945

Abstract

The sternum is known as a relatively common site for bone metastases by a variety of malignant neoplasms. The usual finding is increased radiotracer uptake on bone scintigraphy, and cold metastasis is distinctly unusual. In addition, total nonvisualization of the sternum presenting as bone metastasis is extremely rare. We describe two cases with similar findings (absent sternum showing no activity of the sternal segments on bone scintigraphy), which corresponded to metastatic involvement. These findings were shown to be the first manifestation of hepatocellular carcinoma in one patient and bone metastasis in another patient with ovarian cancer.

Keywords: Ovarian cancer, Hepatocellular carcinoma, Bone metastasis, Sternum, Bone scintigraphy


The sternum is known to be a relatively common site of bone metastasis for a variety of malignancies [1]. The sternal body is the most common site of metastatic involvement, whereas the manubrium and xyphoid process are rarely affected [1, 2]. Sternal metastases are usually visualized as hot spots on bone scintigraphy. Some of the metastases may reveal cold lesions, which appear either as a purely cold areas or as a central cold area with a peripheral rim of increased activity [25]. The primary neoplasm for cold sternal metastasis on bone scintigraphy is breast cancer. Multiple myeloma, lung cancer, renal cell cancer, hepatocellular carcinoma (HCC), lymphoma, thyroid cancer, and colon cancer are less common causes [14]. Metastases to the sternum are considered to be extremely rare in ovarian cancer [59]. Total nonvisualization of the sternal body corresponding to metastatic involvement with disease progression has been reported in a patient with HCC [10]. In contrast to HCC, however, we have not found total nonvisualization of sternal activity presenting as bone metastasis from ovarian cancer. Sternal metastasis can appear infrequently as the initial manifestation of HCC [11, 12] (Fig. 1), whereas it can be a rare, late-appearing finding in ovarian cancer [69]. Sternal metastasis as the first manifestation of bone metastasis is even rarer in recurrent ovarian cancer [79] (Fig. 2). It has been reported that an absent sternum showing no activity of the sternal segments exclusive of the manubrium on bone scintigraphy resulted from congenital lack of ossification of the sternum in a 12-year-old girl who had orbital rhabdomyosarcoma [13]. However, this finding can also be the first manifestation of a malignant disease in a patient who has no history of malignancy or a bony metastasis in a patient who has a history of malignancy. So, when an absent sternum showing no activity of the sternum is identified on bone scintigraphy, it is necessary to keep in mind that this finding may occur as the first manifestation of metastatic disease or may also represent congenital lack of ossification of the sternum.

Fig. 1.

Fig. 1

A 66-year-old man presented with anterior chest swelling of a 2-month duration. He had no other symptoms. a Whole body anterior and b left oblique images of bone scintigraphy showed nonvisualization of the sternal body with normal activity of the manubrium and xyphoid process. c A lateral radiograph of the sternum demonstrated corresponding destruction of the sternal body (white arrows) with an intact manubrium and xyphoid process (open arrows). d Subsequent CT demonstrated destruction of the sternum and adjacent costal cartilage with an overlying soft tissue mass (arrow) and a hepatic mass. Excisional biopsy of the chest wall mass confirmed a metastatic tumor originating from hepatocellular carcinoma. Increased uptake in the shoulders, elbows, hips, knees, and ankles was considered to be malignancy-induced polyarthritis. In this case, sternal metastasis was the first manifestation of the malignancy

Fig. 2.

Fig. 2

A 57-year-old woman who underwent radical hysterectomy with bilateral salpingo-ophorectomy 5 years previously for serous adenocarcinoma of the ovary presented with sternal pain and a left axillary mass of 1-month duration. a Whole body anterior and b left oblique images of bone scintigraphy showed nonvisualization of the sternal body, including the manubrium. c Subsequent CT demonstrated an overlying soft tissue mass with partial destruction of the sternum and costal cartilage (arrows) with left axillary lymphadenopathy. d Lateral view of the maximum-intensity-projection image of PET demonstrated a hypermetabolic mass in the sternal body and manubrium (arrow). Excisional biopsy of the chest wall mass and axillary lymph node confirmed a metastatic tumor originating from serous adenocarcinoma of the ovary. This is a rare case of sternal metastasis from ovarian cancer as the first manifestation of bone metastasis that developed 5 years after initial diagnosis, which was successfully treated with surgery and chemotherapy

References

  • 1.Urovitz EP, Fornasier VL, Czitrom AA. Sternal metastases and associated pathologic fractures. Thorax. 1977;32:444–448. doi: 10.1136/thx.32.4.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Otsuka N, Fukunaga M, Morita K, Ono S, Nagai K. Photon-deficient finding in sternum on bone scintigraphy in patients with malignant disease. Radiat Med. 1990;8:168–172. [PubMed] [Google Scholar]
  • 3.Oates E, Staudinger KM. Spectrum of appearance of cold sternal metastases in adults. Clin Nucl Med. 1989;14:702–703. doi: 10.1097/00003072-198909000-00017. [DOI] [PubMed] [Google Scholar]
  • 4.Carrió I, Estorch M. Cold sternal image as a sign of metastatic involvement. Clin Nucl Med. 1986;11:417–419. doi: 10.1097/00003072-198606000-00013. [DOI] [PubMed] [Google Scholar]
  • 5.Toussirot E, Gallinet E, Augé B, Voillat L, Wendling D. Anterior chest wall malignancies. A review of ten cases. Rev Rhum Engl Ed. 1998;65:397–405. [PubMed] [Google Scholar]
  • 6.Sher-Ahmed A, Buscema J, Sardi A. A case report of recurrent epithelial ovarian cancer metastatic to the sternum, diaphragm, costae, and bowel managed by aggressive secondary cytoreductive surgery without postoperative chemotherapy. Gynecol Oncol. 2002;86:91–94. doi: 10.1006/gyno.2002.6715. [DOI] [PubMed] [Google Scholar]
  • 7.Noguchi H, Mori A. A case of ovarian cancer with metastasis to the sternum and costae. Gynecol Oncol. 1994;52:416–419. doi: 10.1006/gyno.1994.1073. [DOI] [PubMed] [Google Scholar]
  • 8.Chiu TJ, Chen YJ, Huang CH. Massive anterior chest wall metastasis of ovarian cancer and prolonged survival after treatment: a case report. J Reprod Med. 2008;53:373–377. [PubMed] [Google Scholar]
  • 9.Pavlakis G, Mountzios G, Terpos E, Leivaditou A, Papadopoulos G, Papasavas P. Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: a case report and review of the literature. Int J Gynecol Cancer. 2006;16(Suppl 1):299–303. doi: 10.1111/j.1525-1438.2006.00208.x. [DOI] [PubMed] [Google Scholar]
  • 10.Lim ST, Sohn MH, Kwak JY, Yim CY. Bone imaging of sternal metastasis from hepatocellular carcinoma with disease progression. Clin Nucl Med. 2002;27:311–312. doi: 10.1097/00003072-200204000-00023. [DOI] [PubMed] [Google Scholar]
  • 11.Horita K, Okazaki Y, Haragushi A, Natsuaki M, Itoh T. A case of solitary sternal metastasis from unknown primary hepatocellular carcinoma. Nippon Kyobu Geka Gakkai Zasshi. 1996;44:959–964. [PubMed] [Google Scholar]
  • 12.Reed JD, Jr, Fishman EK, Kuhlman JE, Hruban RH. Case report 535: hepatoma metastatic to the sternum. Skeletal Radiol. 1989;18:161–163. doi: 10.1007/BF00350671. [DOI] [PubMed] [Google Scholar]
  • 13.Mandell GA, Heyman S. Absent sternum on bone scan. Clin Nucl Med. 1983;8:327. doi: 10.1097/00003072-198307000-00013. [DOI] [PubMed] [Google Scholar]

Articles from Nuclear Medicine and Molecular Imaging are provided here courtesy of Springer

RESOURCES